| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.62B | +4.5% |
| Cost of Revenue | $1.38B | +9.1% |
| R&D Expense | $391.4M | +16.7% |
| SG&A Expense | $584.2M | +5.6% |
| Operating Income | $676.3M | -13.6% |
| Interest Expense | $11.1M | -84.7% |
| Pre-tax Income | $658.0M | -9.6% |
| Income Tax | $126.7M | +102.5% |
| Net Income | $523.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $542.3M | +1.0% |
| Short-term Investments | $563.0M | +4.0% |
| Accounts Receivable | $679.2M | +0.5% |
| Current Assets | $1.97B | +2.6% |
| Total Assets | $8.30B | +2.0% |
| Current Liabilities | $818.9M | +3.6% |
| Total Liabilities | $3.94B | +9.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.27B | -9.2% |
| Capital Expenditures | $241.3M | -26.7% |
| Investing Cash Flow | -$622.3M | +3.8% |
| Financing Cash Flow | -$634.2M | -12.8% |
| Free Cash Flow | $1.03B | -3.9% |
| -19.6% |
| EPS (Basic) | $3.29 | -18.0% |
| EPS (Diluted) | $3.26 | -17.0% |
| Stockholders' Equity |
| $4.36B |
| -3.7% |